PRMT1 and lung carcinoma: Hence, UCP2' impact on the MCUC in case of elevated PRMT1 activity is further demonstrated by the poor survival prognosis of lung carcinoma patients with combined upregulation of UCP2 and PRMT1 (Madreiter-Sokolowski et al., 2017b).